Onemednet Revenue Growth Rates (ONMD), Current and Historic Growth - CSIMarket
CSIMarket
 


Onemednet Corporation  (NASDAQ: ONMD)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

ONMD's Revenue Growth by Quarter and Year

Onemednet's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ONMD/growth
https://api.csimarket.com/api/v1/companies/ONMD/fundamentals
https://api.csimarket.com/api/v1/companies/ONMD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ONMD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1.02
2nd Quarter June 0.29
1st Quarter March 0.28
FY 1.59





ONMD Revenue third quarter 2026 Y/Y Growth Comment
Onemednet Corporation reported Revenue surge of 752.5% year on year in the third quarter 2026, to $ 1.02 millions, this is lower than Onemednet Corporation's recent average Revenue surge of 14171.26%.

Looking into third quarter 2026 results within Medical Laboratories industry 29 other companies have achieved higher Revenue growth. While Onemednet Corporation' s Revenue doubling of 752.5% ranks overall at the positon no. 3502 in the third quarter 2026.




ONMD Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 752.5 %
2nd Quarter June -
1st Quarter March -
FY   -

Financial Statements
Onemednet's third quarter 2026 Revenue $ 1.02 millions ONMD's Income Statement
Onemednet's third quarter 2025 Revenue $ 0.12 millions Quarterly ONMD's Income Statement


ONMD Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 252.76 %
2nd Quarter June 3.57 %
1st Quarter March -68.54 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #30
Healthcare Sector #471
Overall #3502

Revenue Y/Y Growth Statistics
High Average Low
113800 % 14171.26 % -142.18 %
(Mar 31 2026)   (Sep 30 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #30
Healthcare Sector #471
Overall #3502
Revenue Y/Y Growth Statistics
High Average Low
113800 % 14171.26 % -142.18 %
(Mar 31 2026)   (Sep 30 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Onemednet's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
624.39 % 35.82 % -81.69 %
(Dec 31 2025)  


ONMD's III. Quarter Q/Q Revenue Comment
Onemednet Corporation achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 252.76%, to $ 1.02 millions, from $0.29 millions in the second quarter.
ONMD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Onemednet's Revenue growth quarter on quarter, overall rank is 1290.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #184
Overall #1290
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #184
Overall #1290
Revenue Q/Q Growth Statistics
High Average Low
624.39 % 35.82 % -81.69 %
(Dec 31 2025)  


ONMD's III. Quarter Q/Q Revenue Comment
Onemednet Corporation achieved in the III. Quarter 2026 above company average sequential Revenue doubling of 252.76%, to $ 1.02 millions, from $0.29 millions in the second quarter.
ONMD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Onemednet's Revenue growth quarter on quarter, overall rank is 1290.


Onemednet's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 2.49
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking # 3490
Seqeuential Revenue Change (TTM) 56.6 %
Seq. Revenue Growth (TTM) Overall Ranking # 116


Cumulative Revenue growth Comment
Although Onemednet's Annual Revenue growth year on year were below company's average 14171.26% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 752.5% year on year, from % in Jun 30 2026. In the Sep 30 2026 period, Onemednet had cumulative twelve months Revenue of $ 2 millions compare to of $ 0 millions a year ago.
Singns of progress, but modest, recording beneth usual 56.6 % Revenue advance, from $1.59 millions from the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 470 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2933 to 3490.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 4
Healthcare Sector # 471
Overall # 3490

Revenue TTM Y/Y Growth Statistics
High Average Low
113800 %
14171.26 %
-142.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 37
S&P 500 # 116
Cumulative Revenue growth Comment
Although Onemednet's Annual Revenue growth year on year were below company's average 14171.26% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 752.5% year on year, from % in Jun 30 2026. In the Sep 30 2026 period, Onemednet had cumulative twelve months Revenue of $ 2 millions compare to of $ 0 millions a year ago.
Singns of progress, but modest, recording beneth usual 56.6 % Revenue advance, from $1.59 millions from the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 470 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2933 to 3490.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 4
Healthcare Sector # 471
Overall # 3490

Revenue TTM Y/Y Growth Statistics
High Average Low
113800 %
14171.26 %
-142.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 37
S&P 500 # 116




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ONMD's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Meiragtx Holdings Plc1,074.15%$ 1,074.146 millions
Ibio inc 975.00%$ 975.000 millions
Sintx Technologies Inc 952.88%$ 952.885 millions
Foghorn Therapeutics Inc 924.69%$ 924.690 millions
Nrx Pharmaceuticals Inc 874.79%$ 874.793 millions
Zymeworks Inc 828.73%$ 828.732 millions
Pmgc Holdings Inc 784.90%$ 784.904 millions
Onemednet Corporation731.71%$ 731.707 millions
Catheter Precision Inc 713.27%$ 713.274 millions
Abeona Therapeutics Inc 706.88%$ 706.878 millions
Brightspring Health Services Inc 588.43%$ 588.428 millions
Hcw Biologics Inc 583.54%$ 583.538 millions
Bio Green Med Solution Inc 460.49%$ 460.494 millions
Xencor Inc454.88%$ 454.884 millions
Tonix Pharmaceuticals Holding Corp 423.83%$ 423.830 millions
Nakamoto Inc 396.90%$ 396.897 millions
EBR Systems, Inc.385.65%$ 385.647 millions
Solana Company382.07%$ 382.066 millions


About Onemednet Revenue Growth Rates (ONMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Onemednet Corp (CIK 1849380).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-052480
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Onemednet Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.